Roivant Sciences Ltd. (ROIV) Financial Statements
Roivant Sciences financial statements at a glance
Roivant Sciences reported revenue of $8.26 million for fiscal year 2026 (ended March 31, 2026), down 71.6% from fiscal year 2025. Net income was -$299.77 million, a net margin of 3629.2% loss, and diluted earnings per share were -$0.54.
At the end of fiscal year 2026 it had total assets of $5.71 billion, total liabilities of $416.28 million and shareholders' equity of $4.53 billion, with cash and short-term investments of $4.29 billion and total debt of $107.44 million.
Its operations brought in -$750.35 million of cash; capital spending was $8.21 million, leaving free cash flow of -$758.56 million.
The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.
Figures from company filings, in USD; latest fiscal year ended March 31, 2026.
Roivant Sciences Ltd.
Income Statement
Annual • USD
Roivant Sciences key figures by fiscal year
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $8.3M | $29.1M | $124.8M | $61.3M | $55.3M |
| Gross profit | $7.0M | $28.1M | $109.2M | $48.2M | $46.3M |
| Operating income | -$1.3B | -$1.1B | -$1.1B | -$1.1B | -$1.2B |
| Net income | -$299.8M | -$172.0M | $4.3B | -$1.0B | -$845.3M |
| Diluted EPS | -$0.54 | -$0.24 | $5.23 | -$1.42 | -$1.26 |
| Total assets | $5.7B | $5.4B | $7.2B | $2.4B | $2.6B |
| Total liabilities | $416.3M | $249.7M | $774.0M | $782.0M | $523.7M |
| Shareholders' equity | $4.5B | $4.7B | $6.0B | $1.2B | $1.7B |
| Cash and short-term investments | $4.3B | $4.9B | $6.5B | $1.7B | $2.1B |
| Total debt | $107.4M | $100.2M | $499.7M | $481.4M | $283.9M |
| Operating cash flow | -$750.3M | -$839.5M | -$765.3M | -$843.4M | -$677.7M |
| Capital spending | $8.2M | $4.6M | $1.4M | $12.7M | $17.4M |
| Free cash flow | -$758.6M | -$844.1M | -$766.7M | -$856.1M | -$695.2M |
In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2021.
Questions and answers
What was Roivant Sciences's revenue in fiscal year 2026?
$8.26 million, down 71.6% from $29.05 million in fiscal year 2025.
How much profit does Roivant Sciences make?
Roivant Sciences reported net income of -$299.77 million for fiscal year 2026 (3629.2% of revenue); operating income was -$1.29 billion.
How much cash and debt does Roivant Sciences have?
At the end of fiscal year 2026: cash and short-term investments of $4.29 billion and total debt of $107.44 million.
What is Roivant Sciences's free cash flow?
-$758.56 million in fiscal year 2026 (operating cash flow of -$750.35 million minus capital spending of $8.21 million).
